Debt-to-equity of GlobeStar Therapeutics Corp from 30 Jun 2013 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GlobeStar Therapeutics Corp quarterly Debt-to-equity in % history and change rate from 30 Jun 2013 to 30 Jun 2024.
  • GlobeStar Therapeutics Corp Debt-to-equity for the quarter ending 30 Jun 2024 was -104%, a 3.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GlobeStar Therapeutics Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -104% -3% -3.4% 30 Jun 2024
Q1 2024 -103% -2% -2.1% 31 Mar 2024
Q4 2023 -100% 0% +0.46% 31 Dec 2023
Q3 2023 -100% +1% +0.65% 30 Sep 2023
Q2 2023 -100% 0% +0.46% 30 Jun 2023
Q1 2023 -100% +1% +1.1% 31 Mar 2023
Q4 2022 -100% +8% +7% 31 Dec 2022
Q3 2022 -101% +10% +8.7% 30 Sep 2022
Q2 2022 -101% +14% +12% 30 Jun 2022
Q1 2022 -102% +16% +14% 31 Mar 2022
Q4 2021 -108% +5% +4.3% 31 Dec 2021
Q3 2021 -111% +4% +3.2% 30 Sep 2021
Q2 2021 -114% +2% +1.5% 30 Jun 2021
Q1 2021 -118% 0% +0.33% 31 Mar 2021
Q4 2020 -113% +6% +4.9% 31 Dec 2020
Q3 2020 -114% +4% +3.1% 30 Sep 2020
Q2 2020 -116% 0% +0.16% 30 Jun 2020
Q1 2020 -118% -3% -2.3% 31 Mar 2020
Q4 2019 -119% -5% -4.1% 31 Dec 2019
Q3 2019 -118% -4% -4% 30 Sep 2019
Q2 2019 -116% -5% -4.7% 30 Jun 2019
Q1 2019 -115% -9% -8.1% 31 Mar 2019
Q4 2018 -114% -10% -9.2% 31 Dec 2018
Q3 2018 -113% -11% -11% 30 Sep 2018
Q2 2018 -111% -9% -8.8% 30 Jun 2018
Q1 2018 -107% +2112% +95% 31 Mar 2018
Q4 2017 -104% -615% -120% 31 Dec 2017
Q3 2017 -102% -281% -157% 30 Sep 2017
Q2 2017 -102% -188% -218% 30 Jun 2017
Q1 2017 -2218% -1866% -529% 31 Mar 2017
Q4 2016 510% +940% 31 Dec 2016
Q3 2016 179% +605% 30 Sep 2016
Q2 2016 86% +476% 30 Jun 2016
Q1 2016 -353% +139% +28% 31 Mar 2016
Q4 2015 -430% +51% +11% 31 Dec 2015
Q3 2015 -427% +112% +21% 30 Sep 2015
Q2 2015 -390% +4774% +92% 30 Jun 2015
Q1 2015 -492% -1833% -137% 31 Mar 2015
Q4 2014 -481% -967% -199% 31 Dec 2014
Q3 2014 -538% -1437% -160% 30 Sep 2014
Q2 2014 -5164% -4107% -389% 30 Jun 2014
Q1 2014 1342% 31 Mar 2014
Q4 2013 486% 31 Dec 2013
Q3 2013 899% 30 Sep 2013
Q2 2013 -1057% 30 Jun 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.